Susvimo is also approved to treat age-related macular degeneration, and the medication, ranibizumab, is delivered though a ...

In a partisan vote, the Senate Finance Committee voted to forward the nomination of Robert F. Kennedy Jr. as HHS Secretary to the full Senate ...

The Louisiana Republican, who led a hepatitis B vaccination campaign before entering politics, has expressed concerns about ...

This follows the company’s recent earnings call, where executives discussed the organization’s growth and future plans, ...

Potential threats to HIV care and fallout over the next four years, according to Jose Abrigo, Esq., HIV project director at ...

Much of the association between trauma and suicide risk among university students can be explained by shame, a new study ...

Becky Kamowitz was appointed executive director of The Skin Cancer Foundation in January 2025. She talks about organization’s ...

The new biosimilar, Celltrion’s Avtozma, was approved in both IV and subcutaneous forms to treat inflammatory conditions such as arthritis.

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

A panelist discusses how their institution evaluates biosimilars for formulary inclusion through a systematic review process ...

In a new study, researchers found that time-in-range for healthy blood sugar could be a viable marker of glycemic control and potentially could be used to predict complications of type 1 diabetes.